Alliancebernstein L.P. Crispr Therapeutics Ag Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$110.2 - $156.64 $158,577 - $225,404	-1,439 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$100.84 - $161.89 $58,487 - $93,896	-580 Reduced 28.73%	1,439 $233,000
Q1 2021 May 06, 2021	BUY	$110.72 - $210.04 $77,504 - $147,028	700 Added 53.07%	2,019 $246,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $105,084 - $228,490	1,319 New	1,319 $202,000
Q1 2019 May 14, 2019	SELL	$28.02 - $40.87 $1.69 Million - $2.47 Million	-60,400 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$22.73 - $42.34 $1.37 Million - $2.56 Million	60,400 New	60,400 $1.73 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.